Genmab to Host Post ASH Seminar
Genmab will host a webcast focused on the latest developments in antibody innovation on December 10, 2013 from 7:30PM to 9:30PM CET. The seminar will include discussion of data from studies of ofatumumab and daratumumab presented at the 2013 Annual Meeting of the American Society of Hematology (ASH), Genmab's proprietary antibody technologies and expected performance milestones for 2014. To view the webcast via WebEx click here. WebEx viewers may submit questions during the Q&A portion of the live webcast via the webcast player or by dialing +44 203 426 2845 (international participants) or +1 877 841 4559 (US participants).
Genmab published its Third Quarter 2013 financial results and held a conference call on November 6. Click the following links to access the archived call: Listen to the webcast/podcast; download the podcast; download the slide presentation.
Explore our Download library to access presentations given at investor and scientific conferences, financial reports, images, podcasts and more.